Introduction
those in vivo (Kobayashi et al., 1983b; Cajander et al., 1984; Brannstrom et al., 1987) . Rabbit oocytes that have In the ovary, several gene products have been shown to ovulated in an ex vivo perfusion system will establish be regulated by gonadotropins, among them: VEG/PF normal pregnancies when transferred to a recipient (vascular endothelial growth/permeability factor; Koos, . Thus, the biological pathways 1995), α2-macroglobulin (a protease inhibitor; Gaddythat induce ovulation in this ex vivo system closely mimic Kurten and Richards, 1991) , follicle-stimulating hormone in vivo conditions. In this ex vivo system, we registered (FSH) and luteinizing hormone (LH) receptors (Camp the ability of antisense oligonucleotides to specifically et al., 1991), PGS-2 (prostaglandin endoperoxide synthase reduce C/EBP-β expression. The biological effects of such 2; Wong et al., 1989) , the proto-oncogene c-mos (Keshet a reduction were monitored as the ability of ovaries to et al., 1988) , ovarian aromatase cytochrome P450 (Hickey ovulate in response to exogenous gonadotropins. Gonadoet al., 1990) and cyclin D2 (Sicinski et al., 1996) . Recently, tropin-induced differences in ovarian gene expression have the transcription factors C/EBP-α (Piontkewitz et al., 1993) and C/EBP-β (also known as NF-IL6; Sirois and been used previously to identify genes of potential interest directed against C/EBP-β (AS-β), C/EBP-α (AS-α) or a random isoform of C/EBP-β (LAP) of~32 kDa and, to a variable degree, also sequence with no known similarities to any sequence in GenBank. a slight increase in the inhibitory isoform (LIP) of~16 kDa. Thirty μg Significantly lower number of oocytes ovulated ** (P Ͻ0.01). Values of total protein was loaded in each lane.
are expressed as means Ϯ SEM. The control group did not receive any LH, whereas the other groups were treated with an ovulatory dose of LH with or without various oligonucleotides as indicated in the as regulators of ovulation (Keshet et al., 1988; Wong figure. et al., 1989; Hickey et al., 1990; Camp et al., 1991; Gaddy-Kurten and Richards, 1991; Koos, 1995) . This ex vivo perfusion system enabled us to study the ovulation and is the dominating isoform during gonadotropininduced C/EBP-β expression . rate as a biological end point parameter. Thus, induced differences in gene expression can be monitored with
The data presented in Figure 1 agree well with this. In ovaries treated with an ovulatory dose of gonadotropins, regard to their effect on ovulation per se, not only as a gonadotropin-dependent difference in gene expression. granulosa cells are the major sites of C/EBP-β expression ( Figure 1 ). Furthermore, this experimental approach has the advantage that it allowed us to study direct effects on ovarian function, induced by specific changes in its gene expresSpecific inhibition of C/EBP-β expression induces a decrease in the number of ovulated oocytes sion, eliminating secondary metabolic or hormonal effects originating from extra-ovarian sites.
To study the effect of a decrease in gonadotropin-induced C/EBP-β expression on ovulation, we synthesized phosphorothioate oligonucleotides, AS-β, targeted against
Results
the C/EBP-β transcript. When these oligonucleotides were added, in various concentrations as indicated in Figure 2 ,
C/EBP-β is induced by gonadotropins in the ovary
In order to validate this ex vivo perfusion system further to the perfusion medium~30 min before addition of an ovulatory gonadotropin dose, a significant reduction in with regard to gonadotropin-induced changes in gene expression, we reproduced the previously described inducthe number of ovulated oocytes could be detected. The oligonucleotides directed against C/EBP-β (AS-β, Figure tion of C/EBP-β expression in pre-ovulatory ovaries after an ovulatory dose of gonadotropins in vivo (Sirois and 2) suppressed ovulation dose-dependenly to~5% of that of the LH group ( Figure 2 ). In order to assess the . After stimulation with an ovulatory dose of hCG, a hormone with LH-like effects, we could specificity of the oligonucleotide-induced reduction in number of oocytes ovulated, two control groups were demonstrate an induction of the activating isoform of C/EBP-β. Small immature ovaries (SO; not treated with included in the experiment. One group was treated with oligonucleotides directed against the C/EBP-α transcript gonadotropin) and pre-ovulatory (PO) ovaries express almost no detectable C/EBP-β ( Figure 1 ). The C/EBP-β (AS-α; Figure 2 ). [C/EBP-α is a member of the same family of transcription factors as C/EBP-β. Identical gene is expressed as two isoforms, LAP (32 kDa), a transcriptional activator, and LIP (16 kDa), a transcripoligonucleotides have been used previously to reduce ovarian C/EBP-α expression (Piontkewitz et al., 1996) .] tional repressor (Descombes and Schibler, 1991) . These isoforms are explained by differential use of two AUGs
In another group of experiments, ovaries were treated with a random oligonucleotide with no known sequence within the same transcript (Descombes and Schibler, 1991) . In the ovary, the LAP isoform is the most abundant similarity to any gene. The small decrease of ovulated oocytes in these control groups was not significant, whereas the dose-dependent decrease in number of ovulated oocytes for AS-β at 3 and 10 μM was clearly significant (P Ͻ0.01, Figure 2 ). Ovarian secretion of progesterone and estradiol was increased by LH, which also is the case in vivo. This pattern of secretion was not affected by the presence of any of the oligonucleotides used in this study (Figure 3 ). Figure 4 demonstrates that ovaries perfused with 10 μM antisense oligonucleotides directed against C/EBP-β have lost their expression of the major activating isoform of C/EBP-β (LAP), whereas ovaries treated with either no antisense oligonucleotide, antisense oligonucleotide directed against C/EBP-α or a random oligonucleotide expressed unaffected levels of LAP. Thus, the dosedependent decrease of ovulated oocytes in ovaries treated with antisense oligonucleotides directed against C/EBP-β (Figure 2 ) is specific and agrees well with the findings in and Schibler, 1991; Doppler et al., 1995; Raught et al., 1995) . Typically, in situations where LAP (32 kDa) and Ovaries with decreased C/EBP-β expression LIP (16 kDa) are regulated, these larger immunoforms contain entrapped oocytes remain unaffected (Raught et al., 1995) . The origin of these The decrease in the number of ovulated oocytes and immunoforms is presently unclear; alternative isoforms of amount of immunostainable C/EBP-β in the ovaries treated C/EBP-β as well as post-translationally modified forms with antisense oligonucleotides directed against C/EBP-β of LAP (32 kDa) and/or LIP (16 kDa) have been suggested (Doppler et al., 1995; Raught et al., 1995) .
( Figures 2 and 4) made us interested in the morphology E (50ϫ) . In (A) and (B) the granulosa cell layer stain to a much lesser degree than do surrounding theca cell layers; the cumulus cells (cells surrounding the oocyte) stain more intensively than other granulosa cells. In (D) and (E) there is a much more pronounced staining from the entire granulosa cell layer.
as well as the tissue distribution of C/EBP-β expression. had several large follicles, in the periphery of the ovary, in which the oocytes still were enclosed (not shown). For this purpose, ovaries from three groups, treated with LH only, LH ϩ a random oligonucleotide (10 μM) and Apart from this finding, there was no obvious difference in the morphology when compared with the control groups. LH ϩ C/EBP-β antisense oligonucleotides (10 μM), were fixed, sectioned and stained 20 h after an ovulatory LH In order to evaluate further the tissue distribution of C/EBP-β expression in these three groups of ovaries, we dose had been given. There was a clear difference in morphology. The control groups (LH only and LH ϩ a used immunohistochemistry ( Figure 5 ). In the ovaries treated with LH ϩ C/EBP-β antisense oligonucleotides, a random oligonucleotide), i.e. the groups that ovulated some 15-20 oocytes (Figure 2) , had a wide range of clear reduction of immunostainable C/EBP-β was evident in the granulosa cell layers ( Figure 5A-C) . Sparsely different sized follicles. In the periphery of these ovaries, large follicles were present without visible oocytes, with distributed positive cells within the theca cell layer were also present ( Figure 5A and B) . Furthermore, the cumulus the appearance of follicles that had recently ovulated. These ovaries displayed normal morphology (not shown).
cells, surrounding the entrapped oocyte, exhibited a relatively high level of C/EBP-β expression compared The ovaries that had been treated with LH ϩ C/EBP-β antisense oligonucleotides, which ovulated 0-2 oocytes, with other granulosa cells ( Figure 5A-C) . In sections to be able specifically to reduce ovarian expression of C/EBP-α (Piontkewitz et al., 1996) , nor a non-specific random oligonucleotide, with no known sequence similarity to any gene, were able to affect the expression of C/EBP-β significantly ( Figure 4 ). As one would expect, in the case of a specific and biologically significant decrease in gene expression, only in ovaries with a reduced level of C/EBP-β could we demonstrate these morphological and functional alterations, whereas ovaries derived from the control experiments did not, in any significant respect, differ from ovaries not treated with antisense oligonucleotides. Thus, in this study, we demonstrate that gonadotropin-induced expression of the activating isoform (LAP) of C/EBP-β, is an important factor for ovulation to take place in an ex vivo perfused ovary; (Kobayashi et al., 1983a,b; Cajander et al., 1984; , 1984; Brannstrom et al., 1987) , this ex vivo study in an increase of PGS-2 (72 kDa). Treatment with AS-β or random implicates C/EBP-β as a key regulator of ovulation in vivo.
oligonucleotides did not affect the expression of PGS-2. This is one of
To our knowledge, this is the only demonstration of a three independent experiments showing very similar results; 15 μg of total protein was loaded in each lane.
transcription factor which exhibits a dose dependency between expression level and number of oocytes ovulated in response to gonadotropins. containing the nucleolus, it was evident that this structure also stained positive ( Figure 5C ). In the control groups
After an ovulatory dose of gonadotropin, C/EBP-β is induced promptly in granulosa cells (Sirois and Richards, (LH only and LH ϩ a random oligonucleotide), very few, if any, entrapped oocytes were present. In these groups, 1993) whereas C/EBP-α, another member of the C/EBP family of transcription factors, decreases in granulosa cells the staining pattern was strong and uniformly distributed in the entire granulosa cell population ( Figure 5D and E).
exposed to LH Piontkewitz et al., 1996) . Based on these findings, we speculate that The cells contained within the theca cell layers were stained to a lesser degree when compared with granulosa the role of C/EBP-α is to support follicular differentiation so that ovulation will occur in response to gonadotropins; cells, and the signal was similar to that seen in theca cell layers from the antisense C/EBP-β-treated ovaries; i.e. an on the other hand, C/EBP-β expression seems to be necessary for the ovulation process per se. The reduction unevenly distributed signal ( Figure 5D and E).
in C/EBP-β expression does not seem to affect the expression of PGS-2 ( Figure 6 ). This is in accordance PGS-2 expression is not altered in response to specific inhibition of C/EBP-β with the fact that mutations within the C/EBP-β-binding cis-element in the PGS-2 promoter do not alter this gene's In Figure 6 we show that no major alteration in PGS-2 expression could be detected in any of the groups. This gonadotropin inducibility (Morris and Richards, 1996) . We speculate that an increase in cAMP, due to a surge in suggests that the inhibitory effect on ovulation, specifically mediated by the C/EBP-β antisense oligonucleotides, is LH concentration, would induce both C/EBP-β and PGS-2 in independent of gonadotropin-induced PGS-2 expression. This is in accordance with the finding that an intact PGS-2 pre-ovulatory granulosa cells and that these events are parallel rather than dependent on each other in a linear promoter, in a reporter gene construct, is not dependent on C/EBP-β for its gonadotropin inducibility (Morris and way. Since a decrease in C/EBP-β expression initiates several morphological as well as functional events, without Richards, 1996) . These results suggest that a C/EBP-β-dependent pathway, capable of regulating ovulation, is affecting PGS-2 expression, it is possible that there are several parallel cAMP-dependent pathways regulating independent of PGS-2.
ovulation. The morphological appearance of ovaries with a reduced Discussion level of C/EBP-β resembles that of mice that lack cyclin D2, due to a targeted disruption of this locus (Sicinski In ovaries treated with antisense oligonucleotides directed against the transcription factor C/EBP-β we can demonet al., 1996) . These mice fail to ovulate in response to gonadotropins and their oocytes are not released from the strate: (i) a decrease in gonadotropin-induced ovulation ( Figure 2) ; (ii) a specific decrease in C/EBP-β expression follicles (Sicinski et al., 1996) . Both cyclin D2 and C/EBP-β are expressed in granulosa cells and they are assayed both with immunoblots ( Figure 4 ) and by immunohistochemistry ( Figure 5) ; and (iii) an altered morphology also induced by cAMP (Metz and Ziff, 1991; Sicinski et al., 1996) and gonadotropins (Sirois and Richards, with seemingly entrapped oocytes ( Figure 5 ). This is true only for ovaries with reduced C/EBP-β expression, 1993; Sicinski et al., 1996) . Furthermore, both cyclin D2 and C/EBP-β are known to interact directly and form whereas in ovaries with normal C/EBP-β expression none or very few entrapped oocytes can be demonstrated ( Figure  complexes with the gene product of the granulosa cell expressed retinoblastoma tumor suppressor gene (pRb; 5). In order to confirm a specific decrease in C/EBP-β expression, we have included several controls. Neither a Kato et al., 1993; Bukovsky et al., 1995; Chen et al., 1996) . An intriguing possibility is that several parallel specific control, i.e. an antisense oligonucleotide proven
